Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Epena resin, derived from Virola species bark, contains DMT and 5-MeO-DMT as primary psychoactive alkaloids that act as potent 5-HT2A receptor agonists. The resin disrupts default mode network activity in the brain, traditionally used by Amazonian peoples as a visionary snuff preparation.
Reported Benefits (Provisional)
Origin & History
Epena Resin (Virola spp.) is a psychoactive resin derived from the bark of various Virola trees. It is native to the Western Amazon, found in Colombia, Peru, and Brazil. This resin is traditionally used in shamanic rituals for its neuroprotective and immune-modulating properties, and for energetic purification.
Research Narrative (Provisional)
Scientific studies on Epena Resin primarily focus on its alkaloid content and their pharmacological effects, including neuroprotective and immune-modulating potentials. Research, often involving in vitro and animal models, explores the bioactive compounds responsible for its traditional uses and emerging applications in non-psychoactive extracts.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Alkaloids: Tryptamine alkaloids (N,N-DMT, 5-MeO-DMT traces). - Phytochemicals: Ferulic acid, lignans, terpenoids, polyphenols, caffeic acid, essential oils. - Minerals: Zinc, Selenium.
Reported Mechanism (Provisional)
The primary bioactive compounds DMT and 5-MeO-DMT function as potent serotonin receptor agonists, specifically targeting 5-HT2A receptors. This receptor binding disrupts default mode network activity in the brain, leading to altered states of consciousness and potential neuroprotective effects through modulation of neuroplasticity pathways.
Clinical Narrative (Provisional)
Currently, no randomized controlled trials exist for Epena resin due to its Schedule I classification in many countries. Available evidence consists primarily of ethnographic studies documenting traditional use patterns, with reported doses of 0.5-1g producing effects lasting 15-60 minutes. Scientific research remains limited to in vitro and animal model studies examining alkaloid content and pharmacological properties, with no human clinical data available.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.